<DOC>
	<DOCNO>NCT02307760</DOCNO>
	<brief_summary>The purpose study assess growth preterm infant feed human milk supplement one two commercially available human milk fortifiers .</brief_summary>
	<brief_title>Evaluation Human Milk Fortifiers Preterm Infants</brief_title>
	<detailed_description />
	<criteria>Birth weight 700 g1500 g. ≤ 32 week 0 day GA birth . Appropriate GA ( AGA ) . Enteral feed human milk initiate 21 day life ( birth date day life 0 ) . Mother agree provide human milk exclusive feeding study period ; use donor milk permit plan fortify . Parent ( ) agree allow infant receive human milk HMF . Singleton twin birth . Enteral feed preterm infant formula HMF &gt; 7 day . Expected transfer another facility able follow least 15 day . Serious congenital abnormality underlie disease may affect growth development . 5 minute APGAR ≤ 4 . Steroids use time randomization . Grade III IV periventricular/intraventricular hemorrhage ( PVH/IVH ) . Mechanical ventilator dependence . Maternal incapacity : include maternal cocaine alcohol abuse pregnancy current , mother infant currently receive treatment consistent HIV therapy . Infant history major surgery ( intrathoracic intraabdominal procedure surgery require general anesthesia ) . Asphyxia define progressive hypoxemia hypercapnia significant metabolic acidemia characterize APGAR score &lt; 3 10 minute , seizure within first 12 hour life , cord blood gas &lt; 7.0 seizure and/or severe tonic abnormality first 12 hour life ( 24 ) . Confirmed necrotizing enterocolitis ( Bell 's Stage II III , Appendix J ) confirm sepsis ( positive culture require antibiotic treatment ) . Infant condition , opinion investigator , preclude participation study . Participation another study approve concomitant study AN .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>